B1962 injection for advanced colorectal cancer
Part of Cancer clinical trials.
This trial tests a new injection called B1962 for people with advanced colorectal cancer that has spread or cannot be removed by surgery, and who have already tried standard treatments. The goal is to see if B1962 can help shrink tumors or slow the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have advanced colorectal cancer (colon or rectum) that has spread to other parts of the body or cannot be removed by surgery, and it has gotten worse after standard treatments.
- You have had standard treatments that included the chemotherapy drugs oxaliplatin, irinotecan, and fluorouracil.
- You are willing and able to follow the study schedule and procedures.
- You have at least one tumor that can be measured on a CT scan or MRI.
- Your major organs (like bone marrow, liver, kidneys) are working well enough, based on blood tests.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new drug called RBS2418 for people with advanced colorectal cancer that has spread and is getting worse, even after other treatments have stopped working. The goal is to see if RBS2418 can help control the cancer.
This trial tests a new drug called B1962 for people with advanced solid tumors that have not responded to or can no longer be treated with standard therapies. It is for specific cancers like ovarian, breast, lung, or liver cancer, and you must not have previously taken certain immune-based or anti-angiogenic treatments.
This trial tests a new drug called AT-1965 for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and if it can shrink tumors.
This trial tests a new combination of three drugs for people with advanced colorectal cancer that has not responded to previous treatments. The goal is to see if this combination can help shrink tumors or slow the cancer's growth.
This trial tests two immunotherapy drugs (ADG126 and pembrolizumab) given before surgery for locally advanced colorectal cancer that hasn't spread. It aims to shrink tumors and improve outcomes.
This trial tests a combination of two investigational drugs, MHB036C and MHB039A, in people with advanced breast cancer or other solid tumors that have spread. The goal is to see if this combination can shrink tumors and help patients live longer.
Hear when a new Advanced Colorectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.